<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article article-type="article-commentary" dtd-version="1.1" specific-use="sps-1.9" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="nlm-ta">Rev Saude Publica</journal-id>
			<journal-id journal-id-type="publisher-id">rsp</journal-id>
			<journal-title-group>
				<journal-title>Revista de Saúde Pública</journal-title>
				<abbrev-journal-title abbrev-type="publisher">Rev. Saúde Pública</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="ppub">0034-8910</issn>
			<issn pub-type="epub">1518-8787</issn>
			<publisher>
				<publisher-name>Faculdade de Saúde Pública da Universidade de São Paulo</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="other">00601</article-id>
			<article-id pub-id-type="doi">10.11606/s1518-8787.2022056004314</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Comments</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Impact of covid-19 on people living with HIV-1: care and prevention indicators at a local and nationwide level, Santo André, Brazil</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-0254-4154</contrib-id>
					<name>
						<surname>Matsuda</surname>
						<given-names>Elaine Monteiro</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>I</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-2202-0443</contrib-id>
					<name>
						<surname>Oliveira</surname>
						<given-names>Isabela Penteriche de</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>I</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-5814-6262</contrib-id>
					<name>
						<surname>Bao</surname>
						<given-names>Laura Ballesteros</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>I</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-6665-0987</contrib-id>
					<name>
						<surname>Manzoni</surname>
						<given-names>Fernanda Matsuda</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>I</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-1425-9825</contrib-id>
					<name>
						<surname>Campos</surname>
						<given-names>Norberto Camilo</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>II</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-2467-0677</contrib-id>
					<name>
						<surname>Varejão</surname>
						<given-names>Beatriz Brajal</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>I</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-6749-2300</contrib-id>
					<name>
						<surname>Leal</surname>
						<given-names>Maristelly Pereira</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>II</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-4534-024X</contrib-id>
					<name>
						<surname>Nascimento</surname>
						<given-names>Vania Barbosa</given-names>
					</name>
					<xref ref-type="aff" rid="aff3"><sup>III</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-1022-7837</contrib-id>
					<name>
						<surname>Brígido</surname>
						<given-names>Luís Fernando de Macedo</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>II</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1">
				<label>I</label>
				<institution content-type="orgname">Secretaria da Saúde de Santo André</institution>
				<institution content-type="orgdiv1">Centro Médico de Especialidades – Infectologia</institution>
				<addr-line>
					<named-content content-type="city">Santo André</named-content>
					<named-content content-type="state">São Paulo</named-content>
				</addr-line>
				<country country="BR">Brasil</country>
				<institution content-type="original">Secretaria da Saúde de Santo André. Centro Médico de Especialidades – Infectologia. Santo André, São Paulo, Brasil</institution>
			</aff>
			<aff id="aff2">
				<label>II</label>
				<institution content-type="orgname">Instituto Adolfo Lutz</institution>
				<institution content-type="orgdiv1">Centro de Virologia</institution>
				<addr-line>
					<named-content content-type="city">São Paulo</named-content>
					<named-content content-type="state">São Paulo</named-content>
				</addr-line>
				<country country="BR">Brasil</country>
				<institution content-type="original">Instituto Adolfo Lutz. Centro de Virologia. São Paulo, São Paulo, Brasil</institution>
			</aff>
			<aff id="aff3">
				<label>III</label>
				<institution content-type="orgname">Faculdade de Medicina do ABC</institution>
				<institution content-type="orgdiv1">Pós-Graduação em Saúde Coletiva</institution>
				<addr-line>
					<named-content content-type="city">Santo André</named-content>
					<named-content content-type="state">São Paulo</named-content>
				</addr-line>
				<country country="BR">Brasil</country>
				<institution content-type="original">Faculdade de Medicina do ABC. Pós-Graduação em Saúde Coletiva. Santo André, São Paulo, Brasil</institution>
			</aff>
			<author-notes>
				<corresp id="c01"> Correspondence: Luís Fernando de Macedo Brígido Instituto Adolfo Lutz Centro de Virologia Av. Dr. Arnaldo, 355 05411-001 São Paulo, SP, Brasil E-mail: <email>lubrigido@gmail.com</email>
				</corresp>
				<fn fn-type="con">
					<p><bold>Authors’ Contribution:</bold> Conception, design, supervision and the first draft: EMM. Data curation of HIV clinical information and covid-19 HIV panel: IPO, FMM. Data curation of viral load: NCC, BBV, MPL. Actively search for cases in delay in withdrawing ART: LBB. Writing-review: VBN. Conception, funding acquisition, and final review: LFMB. Approval of final version: EMM, IPO, LBB, FMM, NCC, BBV, MPL, VBN, LFMB.</p>
				</fn>
				<fn fn-type="conflict">
					<p><bold>Conflict of Interest:</bold> The authors declare no conflict of interest.</p>
				</fn>
			</author-notes>
			<pub-date date-type="pub" publication-format="electronic">
				<day>27</day>
				<month>05</month>
				<year>2022</year>
			</pub-date>
			<pub-date date-type="collection" publication-format="electronic">
				<year>2022</year>
			</pub-date>
			<volume>56</volume>
			<elocation-id>37</elocation-id>
			<history>
				<date date-type="received">
					<day>18</day>
					<month>10</month>
					<year>2021</year>
				</date>
				<date date-type="accepted">
					<day>10</day>
					<month>01</month>
					<year>2022</year>
				</date>
			</history>
			<permissions>
				<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
					<license-p> This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </license-p>
				</license>
			</permissions>
			<abstract>
				<title>ABSTRACT</title>
				<p>The world has been dealing with Aids for forty years, covid-19 accentuated societal inequalities and promoted a rupture in care and prevention, including for people living with HIV. We compiled official HIV indicators, analyzed the impact of covid-19 in Brazil, at São Paulo State (SP), and compared it to the municipality of Santo André (in the state of São Paulo), which adopted linkage/retention strategies to mitigate the impact of covid-19. From 2019 to 2020, suppression/adhesion rates remained stable. The number of new treatments decreased both in Brazil (-19.75%) and São Paulo (-16.44%), but not in Santo André, where 80% of new patients started treatment within 30 days from their first TCD4 test (70% in São Paulo and 64% in Brazil). However, PrEP dispensing increased during this period. The distribution of 2,820 HIV self-tests in Santo André lead to only one documented new HIV diagnosis linked to care. Synergistic strategies to swiftly diagnose and connect new cases, ensuring retention as well as rescuing missing patients deserve priority in the fight against HIV, especially in times of covid-19.</p>
			</abstract>
			<kwd-group xml:lang="en">
				<kwd>HIV Infection, prevention &amp; control</kwd>
				<kwd>PrEP</kwd>
				<kwd>Acquired Immunodeficiency Syndrome Virus</kwd>
				<kwd>COVID-19</kwd>
				<kwd>Brazil</kwd>
			</kwd-group>
			<funding-group>
				<award-group>
					<funding-source>CNPq</funding-source>
					<award-id>442776/2019-5</award-id>
				</award-group>
				<award-group>
					<funding-source>Fapesp</funding-source>
					<award-id>2018/14384-9</award-id>
				</award-group>
				<funding-statement>Funding: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq - 442776/2019-5). Fundação de Amparo à Pesquisa do Estado de São Paulo (Fapesp - 2018/14384-9).</funding-statement>
			</funding-group>
			<counts>
				<fig-count count="2"/>
				<table-count count="2"/>
				<equation-count count="0"/>
				<ref-count count="21"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<sec sec-type="intro">
			<title>INTRODUCTION</title>
			<p>The WHO<sup><xref ref-type="bibr" rid="B1">1</xref></sup> declared the coronavirus disease 2019 (covid-19) a pandemic early in 2020. By March 29, 2021, the world had 196,553,009 confirmed cases, including 4,200, 412 deaths. Even though Brazil has 2.7% of the world population, it concentrated 13.3% of all covid-19 cases and 26.9% of all deaths at that time, with more than half a million deaths by July, 2021<sup><xref ref-type="bibr" rid="B2">2</xref> , <xref ref-type="bibr" rid="B3">3</xref></sup> .</p>
			<p>Meanwhile, 40 years after the first documented Aids cases, its pandemic is far from reaching an end. In 2020 it was estimated that 37,700,000 people were living with HIV (PLWH), 1,500,000 new infections occurred during the year, 680,000 deaths related to Aids, with 73% of PLWH receiving antiretroviral therapy (ART)<sup><xref ref-type="bibr" rid="B4">4</xref></sup> . All over the world, health services have been disrupted, including those needed to support prevention, diagnosis, and treatment<sup><xref ref-type="bibr" rid="B5">5</xref> , <xref ref-type="bibr" rid="B6">6</xref></sup> .</p>
			<p>The Brazilian Unified Health System (SUS) ensures access to health and services in a universal, equal, and integral way. Along with free ART for all PLWH and specific policies, Brazil had been a model for Aids response, a leadership that was further shaken in recent years as result of a crisis that originated from cuts and freezes in the budget for health, education, and social assistance<sup><xref ref-type="bibr" rid="B7">7</xref></sup> . SARS-CoV-2 aggravated this scenario both directly, because of covid-19 disease, and indirectly, by disrupting HIV care<sup><xref ref-type="bibr" rid="B8">8</xref> , <xref ref-type="bibr" rid="B9">9</xref></sup> . The covid-19 pandemic has accentuated existing inequalities and made the vulnerable population more vulnerable to hunger, violence, and diseases. The metaphor “we are not in the same boat, but in the same tempestuous sea” expresses the very unequal conditions in coping with covid-19 demands.</p>
			<sec>
				<title>Strategies Adopted at the Santo André Infectious Diseases Outpatient Clinic</title>
				<p>Coinciding with the beginning of the first covid-19 wave in Brazil (March 2020), the Santo André infectious diseases outpatient clinic (SA-IDC), the reference in the care of PLWH in the city, started a research project which aimed to test strategies to improve patient linkage/retention, an initiative that was adapted to the restrictions imposed by covid-19. The main strategies to mitigate the impact of covid-19 were: (i) screening at admission, managing users’ needs; ii) maintenance of new patients’ admission (without prior follow-up or transfer) as much as possible, and linking on the same day of admission; iii) maintenance of antiretroviral dispensing; iv) evaluation of complaints and need for laboratory exam collection at ART withdrawal; v) phone monitoring of newly admitted cases with recalls by the nursing staff until viral suppression was achieved; vi) contact with cases with delays in ART withdrawal for over ten days, first by WhatsApp message and, if unanswered, a home visit was made by the social worker; vii) provision of HIV rapid self-test for users seeking them, after discarding post-exposure prophylaxis (PEP) eligibility and; viii) psychological evaluations were maintained, whenever possible, online.</p>
			</sec>
			<sec>
				<title>Official HIV Care and Prevention Indicators</title>
				<p>We conducted a descriptive study based on data on the Brazilian Ministry of Health official registry of HIV/Aids care and prevention indicators (MS/SVS/Department of Chronic Diseases and Sexually Transmitted Infections) to evaluate whether the strategies adopted in Santo André mitigated the difficulties imposed by the covid-19 pandemic. Information for 2019, 2020, and 2021 (analyzed from figures for its first semester) from Brazil, São Paulo State (SP), and Santo André (SA) were compared<sup><xref ref-type="bibr" rid="B10">10</xref> , <xref ref-type="bibr" rid="B11">11</xref></sup> . Number of T CD4 counts, HIV viral load tests, patients starting treatment, and antiretroviral dispensing were obtained from the covid-19 HIV panel<sup><xref ref-type="bibr" rid="B12">12</xref></sup> . Clinical information<sup><xref ref-type="bibr" rid="B13">13</xref></sup> for 2019 and 2020 on linked patients, late, and timely diagnosis, viralsuppression, and adherence to ART were evaluated. <xref ref-type="table" rid="t1">Table 1</xref> and 2 summarize the indicators provided by the Ministry of Health. <xref ref-type="table" rid="t1">Table 1</xref> shows information from a panel developed to assist and monitor the care provided by states and municipalities concerning the main operational indicators that affect treatment and prevention regarding the HIV epidemic in the years 2019, 2020, and projected for 2021, as well as their variation (2019–2020 and 2020–2021). <xref ref-type="fig" rid="f01">Figure 1</xref> illustrates the proportional variation of the indicators shown in <xref ref-type="table" rid="t1">Table 1</xref><sup><xref ref-type="bibr" rid="B12">12</xref></sup> . <xref ref-type="table" rid="t2">Table 2</xref> shows HIV-related clinical indicators for 2019 and 2020<sup><xref ref-type="bibr" rid="B13">13</xref></sup> .</p>
				<p>
					<table-wrap id="t1">
						<label>Table 1</label>
						<caption>
							<title>HIV care parameters obtained from the covid-19 HIV panel 2019–2021.</title>
						</caption>
						<table frame="hsides" rules="groups">
							<colgroup width="10%">
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="left" style="font-weight:normal">
									</th>
									<th align="left" style="font-weight:normal">
									</th>
									<th>Numbers of ART dispensation</th>
									<th>PLWH linked</th>
									<th>Numbers of CD4 count tests</th>
									<th>Numbers of HIV viral load tests</th>
									<th>PLWH that started ART</th>
									<th>Numbers of HIV self-tested distribution</th>
									<th>Number of PrEP dispensations</th>
									<th>Number of PEP dispensations</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td>Brazil</td>
									<td align="center">2019</td>
									<td align="center">4,844,525</td>
									<td align="center">675,786</td>
									<td align="center">455,554</td>
									<td align="center">919,516</td>
									<td align="center">73,030</td>
									<td align="center">56,703</td>
									<td align="center">50,341</td>
									<td align="center">112,613</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">2020</td>
									<td align="center">4,143,652</td>
									<td align="center">705,261</td>
									<td align="center">306,009</td>
									<td align="center">732,287</td>
									<td align="center">58,933</td>
									<td align="center">172,606</td>
									<td align="center">71,147</td>
									<td align="center">96,419</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">2021<sup>a</sup></td>
									<td align="center">3,900,442</td>
									<td align="center">738,979</td>
									<td align="center">361,648</td>
									<td align="center">864,430</td>
									<td align="center">61,652</td>
									<td align="center">93,972</td>
									<td align="center">86,834</td>
									<td align="center">102,940</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">∆2019–2020</td>
									<td align="center">-14.5</td>
									<td align="center">4.4</td>
									<td align="center">-32.8</td>
									<td align="center">-20.4</td>
									<td align="center">-19.3</td>
									<td align="center">204</td>
									<td align="center">41.3</td>
									<td align="center">-14.4</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">∆2020–2021<sup>a</sup></td>
									<td align="center">-5.9</td>
									<td align="center">4.8</td>
									<td align="center">18.2</td>
									<td align="center">18.0</td>
									<td align="center">4.6</td>
									<td align="center">-45.6</td>
									<td align="center">22.0</td>
									<td align="center">6.8</td>
								</tr>
								<tr>
									<td>São Paulo</td>
									<td align="center">2019</td>
									<td align="center">1,040,794</td>
									<td align="center">163,188</td>
									<td align="center">101,954</td>
									<td align="center">232,568</td>
									<td align="center">13,505</td>
									<td align="center">36,772</td>
									<td align="center">22,320</td>
									<td align="center">41,029</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">2020</td>
									<td align="center">9,31,576</td>
									<td align="center">168,433</td>
									<td align="center">78,400</td>
									<td align="center">197,128</td>
									<td align="center">11,642</td>
									<td align="center">92,666</td>
									<td align="center">34,144</td>
									<td align="center">34,777</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">2021<sup>a</sup></td>
									<td align="center">875,110</td>
									<td align="center">174,340</td>
									<td align="center">89,614</td>
									<td align="center">230,226</td>
									<td align="center">11,742</td>
									<td align="center">54,026</td>
									<td align="center">41,048</td>
									<td align="center">35,908</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">∆2019–2020</td>
									<td align="center">-10.5</td>
									<td align="center">3.2</td>
									<td align="center">-23.1</td>
									<td align="center">-15.2</td>
									<td align="center">-13.8</td>
									<td align="center">152</td>
									<td align="center">53.0</td>
									<td align="center">-15.2</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">∆2020–2021<sup>a</sup></td>
									<td align="center">-6.1</td>
									<td align="center">3.5</td>
									<td align="center">14.3</td>
									<td align="center">16.8</td>
									<td align="center">0.9</td>
									<td align="center">-41.7</td>
									<td align="center">20.2</td>
									<td align="center">3.3</td>
								</tr>
								<tr>
									<td>Santo André</td>
									<td align="center">2019</td>
									<td align="center">17,724</td>
									<td align="center">2,432</td>
									<td align="center">1,249</td>
									<td align="center">3,746</td>
									<td align="center">183</td>
									<td align="center">6</td>
									<td align="center">386</td>
									<td align="center">733</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">2020</td>
									<td align="center">13,956</td>
									<td align="center">2,549</td>
									<td align="center">683</td>
									<td align="center">2,852</td>
									<td align="center">176</td>
									<td align="center">2,820</td>
									<td align="center">457</td>
									<td align="center">706</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">2021<sup>a</sup></td>
									<td align="center">11,716</td>
									<td align="center">2,644</td>
									<td align="center">820</td>
									<td align="center">3,014</td>
									<td align="center">154</td>
									<td align="center">274</td>
									<td align="center">484</td>
									<td align="center">636</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">∆2019–2020</td>
									<td align="center">-21.3</td>
									<td align="center">4.8</td>
									<td align="center">-45.3</td>
									<td align="center">-23.9</td>
									<td align="center">-3.8</td>
									<td align="center">46,900</td>
									<td align="center">18.4</td>
									<td align="center">-3.7</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">∆2020–2021<sup>a</sup></td>
									<td align="center">-16.1</td>
									<td align="center">3.7</td>
									<td align="center">20.1</td>
									<td align="center">5.7</td>
									<td align="center">-12.5</td>
									<td align="center">-90.3</td>
									<td align="center">5.9</td>
									<td align="center">-9.9</td>
								</tr>
							</tbody>
						</table>
						<table-wrap-foot>
							<fn id="TFN1">
								<p>ART: antiretroviral; PLWH: persons living with HIV; PrEP: pre-exposure prophylaxis; PEP: postexposure prophylaxis.</p>
							</fn>
							<fn id="TFN2">
								<p><sup>a</sup> HIV indicators for all the country, São Paulo state and City of Santo André at pre-pandemic (2019) and two pos pandemic years 2020 e 2021, the latter projected from the first semester, and ∆ the variation 2019–2020 and 2020–2021 as percentage of change.</p>
							</fn>
							<attrib>Source: Ministério da Saúde (BR) 2020<sup>12</sup>.</attrib>
						</table-wrap-foot>
					</table-wrap>
				</p>
				<p>
					<fig id="f01">
						<label>Figure 1</label>
						<caption>
							<title>Proportion of variation of covid-19 HIV panel data between 2019–2020 and 2020–2021a.</title>
						</caption>
						<graphic xlink:href="1518-8787-rsp-56-37-gf01.tif"/>
						<attrib>ART: antiretroviral; PLWH, persons living with HIV; PrEP, pre-exposure prophylaxis; PEP, post-exposure prophylaxis.</attrib>
						<attrib><sup>a</sup> Data for 2021 were estimated from data for the first half of 2021, multiplying them by 2.</attrib>
						<attrib>Source: Ministério da Saúde (BR) 2020<sup>12</sup>.</attrib>
					</fig>
				</p>
				<p>
					<table-wrap id="t2">
						<label>Table 2</label>
						<caption>
							<title>HIV clinical indicators (2019–2020) in Brazil, São Paulo state and city of Santo André.</title>
						</caption>
						<table frame="hsides" rules="groups">
							<colgroup width="8%">
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="left" style="font-weight:normal">
									</th>
									<th align="left" style="font-weight:normal">
									</th>
									<th>Late diagnosis (%)</th>
									<th>ART within 30 days (%)</th>
									<th>Linked</th>
									<th>Started ART</th>
									<th>On ART</th>
									<th>Timely start of ART (%)</th>
									<th>Viral suppression (%)</th>
									<th>Sustained suppression (%)</th>
									<th>Sufficient adhesion (%)</th>
									<th>Insufficient adhesion (%)</th>
									<th>Loss of follow-up (%)</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td>Brazil</td>
									<td align="center">2019</td>
									<td align="center">26</td>
									<td align="center">58</td>
									<td align="center">753,316</td>
									<td align="center">68,527</td>
									<td align="center">633,699</td>
									<td align="center">35</td>
									<td align="center">88</td>
									<td align="center">74</td>
									<td align="center">73</td>
									<td align="center">18</td>
									<td align="center">9</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">2020</td>
									<td align="center">27</td>
									<td align="center">64</td>
									<td align="center">757,075</td>
									<td align="center">54,995</td>
									<td align="center">665,080</td>
									<td align="center">35</td>
									<td align="center">89</td>
									<td align="center">76</td>
									<td align="center">78</td>
									<td align="center">13</td>
									<td align="center">9</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">∆2019–2020</td>
									<td align="center">1</td>
									<td align="center">6</td>
									<td align="center">0.50</td>
									<td align="center"><bold>-19.75</bold></td>
									<td align="center">4.95</td>
									<td align="center">0</td>
									<td align="center">1</td>
									<td align="center">2</td>
									<td align="center">5</td>
									<td align="center">-5</td>
									<td align="center">0</td>
								</tr>
								<tr>
									<td>São Paulo</td>
									<td align="center">2019</td>
									<td align="center">23</td>
									<td align="center">61</td>
									<td align="center">179,763</td>
									<td align="center">12,820</td>
									<td align="center">150,986</td>
									<td align="center">38</td>
									<td align="center">90</td>
									<td align="center">76</td>
									<td align="center">75</td>
									<td align="center">16</td>
									<td align="center">10</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">2020</td>
									<td align="center">23</td>
									<td align="center">70</td>
									<td align="center">179,859</td>
									<td align="center">10,713</td>
									<td align="center">158,608</td>
									<td align="center">37</td>
									<td align="center">91</td>
									<td align="center">78</td>
									<td align="center">79</td>
									<td align="center">13</td>
									<td align="center">8</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">∆2019–2020</td>
									<td align="center">0</td>
									<td align="center">9</td>
									<td align="center">0.05</td>
									<td align="center">-16.44</td>
									<td align="center">5.05</td>
									<td align="center">-1</td>
									<td align="center">1</td>
									<td align="center">2</td>
									<td align="center">4</td>
									<td align="center">-3</td>
									<td align="center">-2</td>
								</tr>
								<tr>
									<td>Santo André</td>
									<td align="center">2019</td>
									<td align="center">27</td>
									<td align="center">82</td>
									<td align="center">2,714</td>
									<td align="center">181</td>
									<td align="center">2,381</td>
									<td align="center">43</td>
									<td align="center">92</td>
									<td align="center">78</td>
									<td align="center">80</td>
									<td align="center">14</td>
									<td align="center">6</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">2020</td>
									<td align="center">23</td>
									<td align="center">84</td>
									<td align="center">2,724</td>
									<td align="center">181</td>
									<td align="center">2,449</td>
									<td align="center">31</td>
									<td align="center">93</td>
									<td align="center">80</td>
									<td align="center">87</td>
									<td align="center">6</td>
									<td align="center">7</td>
								</tr>
								<tr>
									<td>
									</td>
									<td align="center">∆2019–2020</td>
									<td align="center">-4</td>
									<td align="center">2</td>
									<td align="center">0.37</td>
									<td align="center"><bold>0.00</bold></td>
									<td align="center">2.86</td>
									<td align="center">-12</td>
									<td align="center">1</td>
									<td align="center">2</td>
									<td align="center">7</td>
									<td align="center">-8</td>
									<td align="center">1</td>
								</tr>
							</tbody>
						</table>
						<table-wrap-foot>
							<fn id="TFN3">
								<p>Data for all the country, only the São Paulo state and only City of Santo André at pre-covid-19 pandemic (2019) and first covid-19 pandemic year (2020), with ∆, variation (percentage).</p>
							</fn>
							<fn id="TFN4">
								<p>ART: antiretroviral; Late diagnosis: percentage of individuals with a first count of T CD4 cells record &lt; 200 cells/mL; Treatment within 30 days: Percentage of individuals eligible for ART who started treatment within one month after performed the first count of T CD4 cells; Linked: number of individuals with at least one dispensation, one T CD4 cells or viral load collection; Started ART: number of individuals who started ART; On ART: number of persons living with HIV (PLWH) on ART (at least one medication dispensing, or withdraw, in the last 100 days); Timely start of ART: proportion of individuals starting ART with T CD4 cells &gt; 500 cells/mL; Viral suppression (percentage of viral suppression): all individuals on ART (dispensed in the last 100 days of the year) who performed viral load, whose result was below 50 copies/mL; Sustained suppression: percentage of individuals on ART (withdraw in the last 100 days of the year, for at least two years and who performed at least 02 viral load tests with results below 50 copies/mL after at least 06 months from the beginning of the treatment; Sufficient adhesion: proportion of individuals with more than 80% ART adherence at the end of each year. Insufficient adhesion: proportion of individuals with at least one withdrawal of ARV, but with more than 80% adherence at the end of each year; Loss of follow-up: proportion of individuals without at least one withdrawal at the end of each year.</p>
							</fn>
							<attrib>Source: Ministério da Saúde (BR) 2021<sup>13</sup>.</attrib>
						</table-wrap-foot>
					</table-wrap>
				</p>
			</sec>
			<sec>
				<title>Consequences of the covid-19 pandemic: not everything got worse</title>
				<p>The response to covid-19 included the cancellation of appointments and the routine collection of tests in all health units in mid-March 2020. The decrease in the number of ART dispensations as treatment shown in <xref ref-type="table" rid="t1">Table 1</xref> and <xref ref-type="fig" rid="f01">Figure 1</xref> , is a result of the increase in the amount of ART dispensed each time from 30 to 90 days, from 8%, 16%, and 6%, in 2019 to 25% in all strata by 2020, representing an increase (17%, 9%, and 19%) in Brazil, São Paulo, and Santo André, respectively. This was an old request that facilitates medication dispensing that should be further expanded. This ART multi-month dispensing policy proved able to contribute both to adherence to HIV treatment as well to a decrease in opportunities for transmission of covid-19<sup><xref ref-type="bibr" rid="B14">14</xref></sup> , moreover, ART is an fundamental tool to control the HIV epidemic, as the “undetectable=untransmittable” policy shows<sup><xref ref-type="bibr" rid="B15">15</xref></sup> .</p>
				<p>While pre-exposure prophylaxis (PrEP) dispensation increased (41%, 53%, and 18%), post-exposure prophylaxis (PEP) dispensation decreased (14%, 15%, and 4%) in 2020, when compared to 2019, in Brazil, São Paulo, and Santo André, respectively. At least in Santo André, where we had access to the details of PEP use, its decrease was due to the 37% reduction in the demand for accidents with biological material, from 155 in 2019 to 98 in 2020, whereas use for consented sexual exposure increased 6%, from 527 in 2019 to 557 in 2020. The increase coincided with a time when contact should have been restricted due to covid-19. PrEP dispensation increased overall due to efforts of national implementation, which was not so evident in Santo André, due to a reduction in the health care team that lead to the suspension of new PrEP program admissions.</p>
				<p>
					<xref ref-type="fig" rid="f02">Figure 2</xref> shows mortality rates in Brazil, São Paulo, and Santo André as the result of the first and second infection waves<sup><xref ref-type="bibr" rid="B10">10</xref> , <xref ref-type="bibr" rid="B11">11</xref></sup> to contextualize the covid-19 pandemic phases. Covid-19 death rates, shown as deaths per 100,000 inhabitants, were estimated by dividing the number of deaths by the estimated population of 2021 (https://www.ibge.gov.br/) and multiplying the result by 100,000. Thus, we obtained 260 (Brazil), 298 (SP), and 335 (SA) deaths per 100,000 inhabitants. The higher documented death rate in Santo André suggests that the city was proportionally more affected by covid-19, with 12% and 29% more deaths/100,000 inhabitants than the state and country, respectively.</p>
				<p>
					<fig id="f02">
						<label>Figure 2</label>
						<caption>
							<title>Mortality rate due to covid-19 in Brazil, in São Paulo State, and the municipality of Santo André.</title>
						</caption>
						<graphic xlink:href="1518-8787-rsp-56-37-gf02.tif"/>
					</fig>
				</p>
				<p>The Santo André public health system prioritizes the diagnosis of HIV infections via HIV rapid tests (RT) performed on SUS health services. The amount of RT performed for diagnosis in 2019, 2020, and in the first half of 2021 was provided by the Santo André health department. Out of 30,910 tests in 2019, 324 (1.1%) were reactive. Out of 28,414 in 2020, 308 (1.1%) were reactive, an 8% decrease in testing. Until June 2021, only 11,997 (113, 0.9% reactive) tests were performed. On the other hand, there was a marked increase in self-tests dispensed, from only six in 2019 to 2,820 in 2020. Those were almost entirely dispensed in the SA-IDC, and 635/2,820 were provided directly in saunas and bars attended by the more vulnerable population. However, among 115 cases admitted without prior follow-up in 2020, only one reported having sought the service due to the reactive result from the self-test obtained free of charge from SUS. 1/2,820, (0.04%) with six additional cases referring a paid self-test acquired in a pharmacy. In the first semester of 2021, only 274 self-tests were dispensed and in-service testing resumed. HIV testing is a cornerstone for prevention and treatment, needed to achieve suppression and break the transmission cycle<sup><xref ref-type="bibr" rid="B15">15</xref></sup> . Albeit the important increase of self-tests dispensed, our observation may suggest that those who buy a test will more likely use it, whereas an individual who receives a test for free, may not do it properly. This needs further evaluation as the effectiveness of this and other modalities of diagnostic incentive are crucial to inform prevention policy.</p>
				<p>New cases linked to the service in the year are estimated by the number of people who started ART. <xref ref-type="fig" rid="f01">Figure 1</xref> and <xref ref-type="table" rid="t1">Table 1</xref> show a different value for people who started ART than what <xref ref-type="table" rid="t2">Table 2</xref> shows, as they used different sources. Santo André has 1.5% (n = 2,644) of PLWH linked in the SA-IDC, and 1.6% (n = 723,889) of the estimated state population in 2021. The SA-IDC, in line with SUS guidelines, does not restrict its services exclusively to residents in Santo André, and even during the greater restriction, it maintained the admission of new diagnoses or transferred cases. The maintained number of patients who started ART in 2020, compared to 2021, reflects this policy, whereas we found a documented reduction of 19.8% in Brazil and 16.4% in SP. The Global Fund’s Results Report 2021 confirms the devastating impact of covid-19 on HIV services, including an 11% decline in prevention services and a 22% reduction in HIV treatment initiation<sup><xref ref-type="bibr" rid="B6">6</xref></sup> .</p>
				<p>The proportion of individuals who start ART within a month after collecting their first TCD4 count test (TimeCD4/ART) may be a proxy for how quickly linking to care occurs. Santo André showed faster linking and maintained more than 80% of its patients in 2020, compared with 70% in São Paulo and 64% in Brazil ( <xref ref-type="table" rid="t2">Table 2</xref> ). The faster TimeCD4/ART in Santo André reflects an effort started in 2018, which aimed to start treatment within seven days of admission. This policy was not associated to any additional loss to follow-up<sup><xref ref-type="bibr" rid="B16">16</xref></sup> . With covid-19, we tried to start treatment on the same day, consistent with the fact that in the presence of exposure risk, we prescribe PEP to mitigate the risk of a new infection. Therefore, we could use the same logic for treating quickly to prevent new infections<sup><xref ref-type="bibr" rid="B17">17</xref></sup> . Worst-case estimates by North American researchers suggest that disruptions in HIV prevention and care during the pandemic may result in a 9% increase in new HIV infections over the next few years<sup><xref ref-type="bibr" rid="B18">18</xref></sup> . Monitoring laboratory tools suffered a major temporary interruption during the initial response to the pandemic. For a while, there was no evidence for a decrease in sustained suppression. However, longer follow-up data are needed to assume the durability of ART suppression.</p>
				<p>Disparities in the social determinants of health and comorbidities likely have a greater influence on the susceptibility of PLWH to covid-19. PLWH bear a disproportionate burden of alcohol, drug use, and mental health disorders, as well as other structural vulnerabilities, which might increase their risk to both viral infections<sup><xref ref-type="bibr" rid="B19">19</xref></sup> . According to data from 37 countries, HIV infection is independently associated with an increased 30% risk of death among patients hospitalized with suspected or confirmed SARS-CoV-2 infection<sup><xref ref-type="bibr" rid="B6">6</xref></sup> . These inequalities in confronting covid-19 should not repeat what happened with Aids. Similar imbalances are emerging and repeating mistakes will be unforgivable. Vaccine disparities are the clearest evidence of this gap. The richest countries must act now to ensure that no one is left behind in the coronavirus vaccine rollout<sup><xref ref-type="bibr" rid="B20">20</xref></sup> .</p>
				<p>Although official Brazilian data show stability in retention and viral suppression of PLWH, careful monitoring in the coming years will be necessary, due to the impoverishment the country is experiencing amid a disruption of social public policies<sup><xref ref-type="bibr" rid="B21">21</xref></sup> , essential for a robust health system. Priorities cannot be neglected, and managers need to use science creatively, adapting the response to local challenges.</p>
			</sec>
		</sec>
	</body>
	<back>
		<ref-list>
			<title>REFERENCES</title>
			<ref id="B1">
				<label>1</label>
				<mixed-citation>1 World Health Organization. Timeline: WHO’s COVID-19 response. Geneva (CH): WHO; 2020 [cited 2021 Jul 31]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline#!">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline#!</ext-link>
				</mixed-citation>
				<element-citation publication-type="webpage">
					<person-group person-group-type="author">
						<collab>World Health Organization</collab>
					</person-group>
					<source>Timeline: WHO’s COVID-19 response</source>
					<publisher-loc>Geneva (CH)</publisher-loc>
					<publisher-name>WHO</publisher-name>
					<year>2020</year>
					<date-in-citation content-type="cited-date">cited 2021 Jul 31</date-in-citation>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline#!">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline#!</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation>2 World Health Organization. Coronavirus (COVID-19) Dashboard. Geneva (CH): WHO; 2021 [cited 2021 Jul 31]. Available from: <ext-link ext-link-type="uri" xlink:href="https://covid19.who.int/">https://covid19.who.int/</ext-link>
				</mixed-citation>
				<element-citation publication-type="webpage">
					<person-group person-group-type="author">
						<collab>World Health Organization</collab>
					</person-group>
					<source>Coronavirus (COVID-19) Dashboard</source>
					<publisher-loc>Geneva (CH)</publisher-loc>
					<publisher-name>WHO</publisher-name>
					<year>2021</year>
					<date-in-citation content-type="cited-date">cited 2021 Jul 31</date-in-citation>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://covid19.who.int/">https://covid19.who.int/</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation>3 Kerr LRFS, Kendall C, Almeida RLF, Ichihara MY, Aquino EML, Silva AAM, et al. COVID-19 in northeast Brazil: first year of the pandemic and uncertainties to come. Rev Saude Publica. 2021;55:35. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.11606/s1518-8787.2021055003728">https://doi.org/10.11606/s1518-8787.2021055003728</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kerr</surname>
							<given-names>LRFS</given-names>
						</name>
						<name>
							<surname>Kendall</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Almeida</surname>
							<given-names>RLF</given-names>
						</name>
						<name>
							<surname>Ichihara</surname>
							<given-names>MY</given-names>
						</name>
						<name>
							<surname>Aquino</surname>
							<given-names>EML</given-names>
						</name>
						<name>
							<surname>Silva</surname>
							<given-names>AAM</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>COVID-19 in northeast Brazil: first year of the pandemic and uncertainties to come</article-title>
					<source>Rev Saude Publica</source>
					<year>2021</year>
					<volume>55</volume>
					<size units="pages">35</size>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.11606/s1518-8787.2021055003728">https://doi.org/10.11606/s1518-8787.2021055003728</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation>4 World Health Organization. Global HIV Programme. Geneva (CH): WHO: 2020 [cited 2021 Aug 1]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statistics">https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statistics</ext-link>
				</mixed-citation>
				<element-citation publication-type="webpage">
					<person-group person-group-type="author">
						<collab>World Health Organization</collab>
					</person-group>
					<source>Global HIV Programme</source>
					<publisher-loc>Geneva (CH)</publisher-loc>
					<publisher-name>WHO</publisher-name>
					<year>2020</year>
					<date-in-citation content-type="cited-date">cited 2021 Aug 1</date-in-citation>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statistics">https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statistics</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation>5 World Health Organization. Global progress report on HIV, viral hepatitis, and sexually transmitted infections, 2021. Geneva (CH): WHO; 2021 [cited 2021 Aug 1]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications/i/item/9789240027077/">https://www.who.int/publications/i/item/9789240027077/</ext-link>
				</mixed-citation>
				<element-citation publication-type="webpage">
					<person-group person-group-type="author">
						<collab>World Health Organization</collab>
					</person-group>
					<source>Global progress report on HIV, viral hepatitis, and sexually transmitted infections, 2021</source>
					<publisher-loc>Geneva (CH)</publisher-loc>
					<publisher-name>WHO</publisher-name>
					<year>2021</year>
					<date-in-citation content-type="cited-date">cited 2021 Aug 1</date-in-citation>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications/i/item/9789240027077/">https://www.who.int/publications/i/item/9789240027077/</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation>6 Ford N, Vitoria M, Doherty M. WHO guidance to support HIV care models during the Covid-19 era. Clin Infect Dis. 2021 Sept 24:ciab855. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/cid/ciab855">https://doi.org/10.1093/cid/ciab855</ext-link>. Epub ahead of print.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ford</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Vitoria</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Doherty</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>WHO guidance to support HIV care models during the Covid-19 era</article-title>
					<source>Clin Infect Dis</source>
					<year>2021</year>
					<month>09</month>
					<day>24</day>
					<comment>ciab855</comment>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/cid/ciab855">https://doi.org/10.1093/cid/ciab855</ext-link>
					</comment>
					<comment>Epub ahead of print</comment>
				</element-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation>7 Daniels JP. COVID-19 threatens HIV care continuity in Brazil. Lancet HIV. 2020;7(12):e804-5. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S2352-3018(20)30312-X">https://doi.org/10.1016/S2352-3018(20)30312-X</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Daniels</surname>
							<given-names>JP</given-names>
						</name>
					</person-group>
					<article-title>COVID-19 threatens HIV care continuity in Brazil</article-title>
					<source>Lancet HIV</source>
					<year>2020</year>
					<volume>7</volume>
					<issue>12</issue>
					<fpage>e804</fpage>
					<lpage>e805</lpage>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S2352-3018(20)30312-X">https://doi.org/10.1016/S2352-3018(20)30312-X</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation>8 Fodjo JNS, Villela EFM, Van Hees S, Vanholder P, Reyntiens P, Colebunders R. Follow-up survey of the impact of covid-19 on people living with hiv during the second semester of the pandemic. Int J Environ Res Public Health. 2021;18(9):4635. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/ijerph18094635">https://doi.org/10.3390/ijerph18094635</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Fodjo</surname>
							<given-names>JNS</given-names>
						</name>
						<name>
							<surname>Villela</surname>
							<given-names>EFM</given-names>
						</name>
						<name>
							<surname>Van Hees</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Vanholder</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Reyntiens</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Colebunders</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title>Follow-up survey of the impact of covid-19 on people living with hiv during the second semester of the pandemic</article-title>
					<source>Int J Environ Res Public Health</source>
					<year>2021</year>
					<volume>18</volume>
					<issue>9</issue>
					<size units="pages">4635</size>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/ijerph18094635">https://doi.org/10.3390/ijerph18094635</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation>9 Beyrer C. A pandemic anniversary: 40 years of HIV/AIDS. Lancet. 2021;397(10290):2142-3. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(21)01167-3">https://doi.org/10.1016/S0140-6736(21)01167-3</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Beyrer</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>A pandemic anniversary: 40 years of HIV/AIDS</article-title>
					<source>Lancet</source>
					<year>2021</year>
					<volume>397</volume>
					<issue>10290</issue>
					<fpage>2142</fpage>
					<lpage>2143</lpage>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(21)01167-3">https://doi.org/10.1016/S0140-6736(21)01167-3</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation>10 Secretaria Municipal de Saúde de São Paulo, Coordenadoria de Vigilância em Saúde. Boletins Oficiais Covid-19. [cited 2021 Aug 10]. <ext-link ext-link-type="uri" xlink:href="https://www.prefeitura.sp.gov.br/cidade/secretarias/saude/vigilancia_em_saude/doencas_e_agravos/coronavirus/index.php?p=295572">https://www.prefeitura.sp.gov.br/cidade/secretarias/saude/vigilancia_em_saude/doencas_e_agravos/coronavirus/index.php?p=295572</ext-link>
				</mixed-citation>
				<element-citation publication-type="webpage">
					<person-group person-group-type="author">
						<collab>Secretaria Municipal de Saúde de São Paulo</collab>
						<collab>Coordenadoria de Vigilância em Saúde</collab>
					</person-group>
					<source>Boletins Oficiais Covid-19</source>
					<date-in-citation content-type="cited-date">cited 2021 Aug 10</date-in-citation>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://www.prefeitura.sp.gov.br/cidade/secretarias/saude/vigilancia_em_saude/doencas_e_agravos/coronavirus/index.php?p=295572">https://www.prefeitura.sp.gov.br/cidade/secretarias/saude/vigilancia_em_saude/doencas_e_agravos/coronavirus/index.php?p=295572</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<mixed-citation>11 Prefeitura de Santo André. Boletins Oficiais Covid-19 - Santo André. [cited 2021 August 10]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www2.santoandre.sp.gov.br/index.php/boletins-oficiais-covid-19-coronavirus">https://www2.santoandre.sp.gov.br/index.php/boletins-oficiais-covid-19-coronavirus</ext-link>
				</mixed-citation>
				<element-citation publication-type="webpage">
					<person-group person-group-type="author">
						<collab>Prefeitura de Santo André</collab>
					</person-group>
					<source>Boletins Oficiais Covid-19 - Santo André</source>
					<date-in-citation content-type="cited-date">cited 2021 August 10</date-in-citation>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://www2.santoandre.sp.gov.br/index.php/boletins-oficiais-covid-19-coronavirus">https://www2.santoandre.sp.gov.br/index.php/boletins-oficiais-covid-19-coronavirus</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<mixed-citation>12 Ministério da Saúde (BR), Secretaria de Vigilância em Saúde, Departamento de Condições Crônicas e Infecções Sexualmente Transmissíveis. Painel de monitoramento de dados de HIV durante a pandemia da COVID-19. Brasília, DF; 2020 [cited 2021 Sept 1]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.aids.gov.br/pt-br/painelcovidHIV">http://www.aids.gov.br/pt-br/painelcovidHIV</ext-link>
				</mixed-citation>
				<element-citation publication-type="webpage">
					<person-group person-group-type="author">
						<collab>Ministério da Saúde (BR)</collab>
						<collab>Secretaria de Vigilância em Saúde</collab>
						<collab>Departamento de Condições Crônicas e Infecções Sexualmente Transmissíveis</collab>
					</person-group>
					<source>Painel de monitoramento de dados de HIV durante a pandemia da COVID-19</source>
					<publisher-loc>Brasília, DF</publisher-loc>
					<year>2020</year>
					<date-in-citation content-type="cited-date">cited 2021 Sept 1</date-in-citation>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="http://www.aids.gov.br/pt-br/painelcovidHIV">http://www.aids.gov.br/pt-br/painelcovidHIV</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<mixed-citation>13 Ministério da Saúde (BR), Secretaria de Vigilância em Saúde, Departamento de Condições Crônicas e Infecções Sexualmente Transmissíveis. Indicadores e dados básicos de monitoramento clínico de HIV. Brasília, DF; 2021 [cited 2021 Sept 1]. Available from: <ext-link ext-link-type="uri" xlink:href="http://indicadoresclinicos.aids.gov.br">http://indicadoresclinicos.aids.gov.br</ext-link>
				</mixed-citation>
				<element-citation publication-type="webpage">
					<person-group person-group-type="author">
						<collab>Ministério da Saúde (BR)</collab>
						<collab>Secretaria de Vigilância em Saúde</collab>
						<collab>Departamento de Condições Crônicas e Infecções Sexualmente Transmissíveis</collab>
					</person-group>
					<source>Indicadores e dados básicos de monitoramento clínico de HIV</source>
					<publisher-loc>Brasília, DF</publisher-loc>
					<year>2021</year>
					<date-in-citation content-type="cited-date">cited 2021 Sept 1</date-in-citation>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="http://indicadoresclinicos.aids.gov.br">http://indicadoresclinicos.aids.gov.br</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<mixed-citation>14 Gatechompol S, Avihingsanon A, Putcharoen O, Ruxrungtham K, Kuritzkes DR. COVID-19 and HIV infection co-pandemics and their impact: a review of the literature. AIDS Res Ther. 2021;18:28. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12981-021-00335-1">https://doi.org/10.1186/s12981-021-00335-1</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Gatechompol</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Avihingsanon</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Putcharoen</surname>
							<given-names>O</given-names>
						</name>
						<name>
							<surname>Ruxrungtham</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Kuritzkes</surname>
							<given-names>DR</given-names>
						</name>
					</person-group>
					<article-title>COVID-19 and HIV infection co-pandemics and their impact: a review of the literature</article-title>
					<source>AIDS Res Ther</source>
					<year>2021</year>
					<volume>18</volume>
					<size units="pages">28</size>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12981-021-00335-1">https://doi.org/10.1186/s12981-021-00335-1</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B15">
				<label>15</label>
				<mixed-citation>15 Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al; PARTNER Study Group. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393(10189):2428-38. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(19)30418-0">https://doi.org/10.1016/S0140-6736(19)30418-0</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Rodger</surname>
							<given-names>AJ</given-names>
						</name>
						<name>
							<surname>Cambiano</surname>
							<given-names>V</given-names>
						</name>
						<name>
							<surname>Bruun</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Vernazza</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Collins</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Degen</surname>
							<given-names>O</given-names>
						</name>
						<etal>et al</etal>
						<collab>PARTNER Study Group</collab>
					</person-group>
					<article-title>Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study</article-title>
					<source>Lancet</source>
					<year>2019</year>
					<volume>393</volume>
					<issue>10189</issue>
					<fpage>2428</fpage>
					<lpage>2438</lpage>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(19)30418-0">https://doi.org/10.1016/S0140-6736(19)30418-0</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B16">
				<label>16</label>
				<mixed-citation>16 Matsuda EM, Oliveira IP, Silva VO, Ahagon CM, Campos IB, Colpas DR, et al. Same week: feasibility of rapid antiretroviral initiation in Brazil Re:GEN Open. 2021 Jun 1;1(1):68-74. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/regen.2021.0030">https://doi.org/10.1089/regen.2021.0030</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Matsuda</surname>
							<given-names>EM</given-names>
						</name>
						<name>
							<surname>Oliveira</surname>
							<given-names>IP</given-names>
						</name>
						<name>
							<surname>Silva</surname>
							<given-names>VO</given-names>
						</name>
						<name>
							<surname>Ahagon</surname>
							<given-names>CM</given-names>
						</name>
						<name>
							<surname>Campos</surname>
							<given-names>IB</given-names>
						</name>
						<name>
							<surname>Colpas</surname>
							<given-names>DR</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Same week: feasibility of rapid antiretroviral initiation in Brazil</article-title>
					<source>Re:GEN Open</source>
					<year>2021</year>
					<month>06</month>
					<day>1</day>
					<volume>1</volume>
					<issue>1</issue>
					<fpage>68</fpage>
					<lpage>74</lpage>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/regen.2021.0030">https://doi.org/10.1089/regen.2021.0030</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B17">
				<label>17</label>
				<mixed-citation>17 Matsuda EM, Coelho LPO, Ahagon CM, Campos IB, Brígido LFM. Immediate start of antiretroviral, why not? Braz J Infect Dis. 2018;22(3):250-1. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bjid.2018.05.006">https://doi.org/10.1016/j.bjid.2018.05.006</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Matsuda</surname>
							<given-names>EM</given-names>
						</name>
						<name>
							<surname>Coelho</surname>
							<given-names>LPO</given-names>
						</name>
						<name>
							<surname>Ahagon</surname>
							<given-names>CM</given-names>
						</name>
						<name>
							<surname>Campos</surname>
							<given-names>IB</given-names>
						</name>
						<name>
							<surname>Brígido</surname>
							<given-names>LFM</given-names>
						</name>
					</person-group>
					<article-title>Immediate start of antiretroviral, why not?</article-title>
					<source>Braz J Infect Dis</source>
					<year>2018</year>
					<volume>22</volume>
					<issue>3</issue>
					<fpage>250</fpage>
					<lpage>251</lpage>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bjid.2018.05.006">https://doi.org/10.1016/j.bjid.2018.05.006</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B18">
				<label>18</label>
				<mixed-citation>18 Duong D. Should COVID-19 testing programs also screen for HIV? CMAJ. 2021;193(19):E702-3. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1503/cmaj.1095940">https://doi.org/10.1503/cmaj.1095940</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Duong</surname>
							<given-names>D</given-names>
						</name>
					</person-group>
					<article-title>Should COVID-19 testing programs also screen for HIV?</article-title>
					<source>CMAJ</source>
					<year>2021</year>
					<volume>193</volume>
					<issue>19</issue>
					<fpage>E702</fpage>
					<lpage>E703</lpage>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1503/cmaj.1095940">https://doi.org/10.1503/cmaj.1095940</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B19">
				<label>19</label>
				<mixed-citation>19 Lesko CR, Bengtson AM. HIV and COVID-19: intersecting epidemics with many unknowns. Am J Epidemiol. 2021;190(1):10-6. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/aje/kwaa158">https://doi.org/10.1093/aje/kwaa158</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lesko</surname>
							<given-names>CR</given-names>
						</name>
						<name>
							<surname>Bengtson</surname>
							<given-names>AM</given-names>
						</name>
					</person-group>
					<article-title>HIV and COVID-19: intersecting epidemics with many unknowns</article-title>
					<source>Am J Epidemiol</source>
					<year>2021</year>
					<volume>190</volume>
					<issue>1</issue>
					<fpage>10</fpage>
					<lpage>16</lpage>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/aje/kwaa158">https://doi.org/10.1093/aje/kwaa158</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B20">
				<label>20</label>
				<mixed-citation>20 The Lancet HIV. Do not repeat mistakes from HIV in the COVID-19 response [editorial]. Lancet HIV. 2021;8(2):e59. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S2352-3018(21)00001-1">https://doi.org/10.1016/S2352-3018(21)00001-1</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>The Lancet</surname>
							<given-names>HIV</given-names>
						</name>
					</person-group>
					<article-title>Do not repeat mistakes from HIV in the COVID-19 response [editorial]</article-title>
					<source>Lancet HIV</source>
					<year>2021</year>
					<volume>8</volume>
					<issue>2</issue>
					<elocation-id>e59</elocation-id>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S2352-3018(21)00001-1">https://doi.org/10.1016/S2352-3018(21)00001-1</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B21">
				<label>21</label>
				<mixed-citation>21 Shadmi E, Chen Y, Dourado I, Faran-Perach I, Furler J, Hangoma P, et al. Health equity and COVID-19: global perspectives. Int J Equity Health. 2020;19:104. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12939-020-01218-z">https://doi.org/10.1186/s12939-020-01218-z</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Shadmi</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Dourado</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Faran-Perach</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Furler</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Hangoma</surname>
							<given-names>P</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Health equity and COVID-19: global perspectives</article-title>
					<source>Int J Equity Health</source>
					<year>2020</year>
					<volume>19</volume>
					<size units="pages">104</size>
					<comment>
						<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12939-020-01218-z">https://doi.org/10.1186/s12939-020-01218-z</ext-link>
					</comment>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
			<fn fn-type="financial-disclosure" id="fn2">
				<p><bold>Funding:</bold>
 <italic>Conselho Nacional de Desenvolvimento Científico e Tecnológico</italic> (CNPq - 442776/2019-5). <italic>Fundação de Amparo à Pesquisa do Estado de São Paulo</italic> (Fapesp - 2018/14384-9).</p>
			</fn>
		</fn-group>
	</back>
</article>